Toggle Search

  1. Home
  2. ...
  3. Press releases
  4. Unilever receives positive opinion on health claim for tea from the EFSA

Unilever receives positive opinion on health claim for tea from the EFSA

London/Rotterdam – Unilever, the world’s leading tea company, today announced that the European Food Safety Authority (EFSA) has issued a positive opinion on the company’s evidence that black tea improves attention. This makes Unilever the first company in the EU to receive a positive scientific opinion on a health claim for tea from the EFSA.

Cup of tea

Dr Amelia Jarman, R&D Director and lead scientist at Unilever said: “Some initial evidence suggested that black tea could improve attention, which is the ability to concentrate on, filter and utilise incoming sensory information. So, we set out to generate the scientific evidence to confirm this.”

Working with external academic experts, Unilever ran three pivotal human intervention studies in which volunteers drank two to three servings of either black tea or coloured and tea-flavoured water on separate occasions. The volunteers undertook a series of tasks to measure attention before and after each serving. Participants were tested on both the accuracy and speed of their responses. The results consistently showed that after drinking black tea, the attention scores were higher. One of the studies, which is proprietary, demonstrated that the stronger the tea, the higher the attention scores.

Clive Gristwood, Executive Vice President R&D Foods & Refreshment at Unilever, said: “It is very valuable for us to have this official positive scientific opinion from the European Food Safety Authority. We are pleased to be one of the few companies to achieve this and we consider it a reward for our long years of extensive research in the benefits associated with drinking tea.”

The EFSA published its public opinion that “owing to its caffeine content, black tea improves attention”, on 24 May 2018, which was followed by a 30-day period of consultation.

The European Commission will now review the EFSA opinion. If the application is granted, Unilever will have exclusive rights to use this health claim for a period of five years.

Read the full published opinion on the EFSA’s website.

ENDS

Unilever PLC

Unilever House
100 Victoria Embankment
London EC4Y 0DY
United Kingdom

+44 (0) 207 822 5252
Press-Office.London@Unilever.com

Unilever NV

Weena 455
3013AL Rotterdam

www.unilever.nl

+31 (0) 10 217 4000
mediarelations.rotterdam@Unilever.com

Safe Harbour

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the 'Group'). They are not historical facts, nor are they guarantees of future performance.

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; inability to find sustainable solutions to support long-term growth; the effect of climate change on Unilever's business; customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain; the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; successful execution of acquisitions, divestitures and business transformation projects; economic and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission, including in the Annual Report on Form 20-F 2017 and the Unilever Annual Report and Accounts 2017.

Explore more on these topics:
Back to top